Search Results - "Toni Danilo"
-
1
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
Published in The New England journal of medicine (16-05-2019)“…In a randomized trial, dabigatran (110 mg per day or 150 mg per day) was no more effective than aspirin (100 mg per day) in preventing a second stroke after an…”
Get full text
Journal Article -
2
Incidence and 10-Year Survival of Intracerebral Hemorrhage in a Population-Based Registry
Published in Stroke (1970) (01-02-2009)“…BACKGROUND AND PURPOSE—The purpose of this study was to evaluate the incidence and prognosis of intracerebral hemorrhage. METHODS—We analyzed data referring to…”
Get full text
Journal Article -
3
Diabetic retinopathy, diabetic macular edema, and cardiovascular risk: the importance of a long-term perspective and a multidisciplinary approach to optimal intravitreal therapy
Published in Acta diabetologica (01-05-2020)“…Diabetic retinopathy (DR), diabetic macular edema (DME), and cardiovascular disease (CVD) resulting from vascular damage from persistently elevated blood…”
Get full text
Journal Article -
4
Acute ischemic stroke in childhood: a comprehensive review
Published in European journal of pediatrics (01-01-2022)“…This review provides an updated analysis of the main aspects involving the diagnosis and the management of children with acute ischemic stroke. Acute ischemic…”
Get full text
Journal Article -
5
STARTING-SICH Nomogram to Predict Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis for Stroke
Published in Stroke (1970) (01-02-2018)“…BACKGROUND AND PURPOSE—Symptomatic intracerebral hemorrhage (sICH) is a rare but the most feared complication of intravenous thrombolysis for ischemic stroke…”
Get full text
Journal Article -
6
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials
Published in The Lancet (British edition) (15-05-2010)“…Summary Background Early administration of intravenous recombinant tissue plasminogen activator (rt-PA) after ischaemic stroke improves outcome. Previous…”
Get full text
Journal Article -
7
Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis
Published in Lancet neurology (01-08-2016)“…Summary Background Randomised trials have shown that alteplase improves the odds of a good outcome when delivered within 4·5 h of acute ischaemic stroke…”
Get full text
Journal Article -
8
Hemorrhagic risk after intravenous thrombolysis for ischemic stroke in patients with cerebral microbleeds and white matter disease
Published in Neurological sciences (01-05-2021)“…Objectives Aim of this study was to evaluate the association between cerebral microbleeds (CMBs) and white matter disease (WMD) with intracerebral hemorrhage…”
Get full text
Journal Article -
9
Implementation and outcome of thrombolysis with alteplase 3–4·5 h after an acute stroke: an updated analysis from SITS-ISTR
Published in Lancet neurology (01-09-2010)“…Summary Background In September, 2008, the European Acute Stroke Study III (ECASS III) randomised trial and the Safe Implementation of Treatment in…”
Get full text
Journal Article -
10
Extending the time window for intravenous thrombolysis in acute ischemic stroke using magnetic resonance imaging-based patient selection
Published in International journal of stroke (01-07-2019)“…Background Intravenous thrombolysis with alteplase within a time window up to 4.5 h is the only approved pharmacological treatment for acute ischemic stroke…”
Get full text
Journal Article -
11
Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study
Published in The Lancet (British edition) (01-01-2007)“…Summary Background The aim of the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST) was to assess the safety and efficacy of…”
Get full text
Journal Article -
12
Thrombolysis with alteplase 3–4·5 h after acute ischaemic stroke (SITS-ISTR): an observational study
Published in The Lancet (British edition) (2008)“…Summary Background Intravenous alteplase is approved for use within 3 h of ischaemic stroke onset, although a meta-analysis of randomised controlled trials…”
Get full text
Journal Article -
13
Intravenous Alteplase for Stroke in Those Older Than 80 Years Old
Published in Stroke (1970) (01-11-2010)“…Risks and benefits of intravenous thrombolysis for patients with stroke > 80 years of age are unclear. We examined outcomes and symptomatic intracerebral…”
Get full text
Journal Article -
14
" Time lost is clot resolution lost ": the neglected perspective of the therapeutic time window for ischemic stroke
Published in Frontiers in neurology (24-05-2023)Get full text
Journal Article -
15
Consensus statements and recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 11–13 November 2018
Published in European stroke journal (01-12-2019)“…The purpose of the European Stroke Organisation–Karolinska Stroke Update Conference is to provide updates on recent stroke therapy research and to give an…”
Get full text
Journal Article -
16
-
17
A survey on clinical pathways of patients with epilepsy and cerebrovascular diseases or brain tumors
Published in Neurological sciences (01-06-2020)“…Objective Patients with seizures and epilepsies comorbid with cerebrovascular disorders (CVDs) or brain tumors (BTs) are managed by different specialists,…”
Get full text
Journal Article -
18
Clinical pathways of epileptic seizures and status epilepticus: results from a survey in Italy
Published in Neurological sciences (01-06-2020)“…Summary Objective Patients with seizures or status epilepticus (SE) access the hospital through emergency departments and may be admitted into different wards…”
Get full text
Journal Article -
19
Evidence of SARS-CoV-2 spike protein on retrieved thrombi from COVID-19 patients
Published in Journal of hematology and oncology (16-08-2022)“…Abstract The pathophysiology of COVID-19-associated coagulopathy is complex and not fully understood. SARS-CoV-2 spike protein (SP) may activate platelets and…”
Get full text
Journal Article -
20
The START nomogram for individualized prediction of the probability of unfavorable outcome after intravenous thrombolysis for stroke
Published in International journal of stroke (01-10-2018)“…Background and purpose The nomogram is an important component of modern medical decision-making, which calculates the probability of an event entirely based on…”
Get full text
Journal Article